Reviews Becaplermin


No reviews yet.

Regranex Drug Description
Regranex® Gel 0.01%
(becaplermin)

WARNING
An increased rate of mortality secondary to malignancy was observed in patients
treated with 3 or more tubes of REGRANEX Gel in a post-marketing retrospective
cohort study. REGRANEX Gel should only be used when the benefits can be expected
to outweigh the risks. REGRANEX Gel should be used with caution in patients
with known malignancy. (See CONTRAINDICATIONS
and WARNINGS)

DRUG DESCRIPTION



What are the possible side effects of becaplermin topical (Regranex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using becaplermin topical and call your doctor at once if you have severe itching, redness, blistering, peeling, or other skin irritation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Regranex »




REGRANEX® Gel contains becaplermin, a recombinant human platelet-derived
growth factor (rhPDGF-BB) for topical administration. Becaplermin is produced
by recombinant DNA technology by insertion of the gene for the B chain of platelet-derived
growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin
has a molecular weight of approximately 25 KD and is a homodimer composed of
two identical poly-peptide chains that are bound together by disulfide bonds.
Becaplermin Concentrate is produced by Novartis Vaccines and Diagnostics, Inc.
and supplied to OMJ Pharmaceuticals under a shared manufacturing arrangement.
REGRANEX Gel is a non-sterile, low biobur-den, preserved, sodium carboxymethylcellulose-based
(CMC) topical gel, containing the active ingredient becaplermin and the following
inactive ingredients: sodium chloride, sodium acetate trihydrate, glacial acetic
acid, water for injection, and methyl-paraben, propylparaben, and m-cresol as
preservatives and l-lysine hydrochloride as a stabilizer. Each gram of REGRANEX
Gel contains 100 μg of becaplermin.Last reviewed on RxList: 11/17/2008




Regranex Drug Description
Regranex® Gel 0.01%
(becaplermin)

WARNING
An increased rate of mortality secondary to malignancy was observed in patients
treated with 3 or more tubes of REGRANEX Gel in a post-marketing retrospective
cohort study. REGRANEX Gel should only be used when the benefits can be expected
to outweigh the risks. REGRANEX Gel should be used with caution in patients
with known malignancy. (See CONTRAINDICATIONS
and WARNINGS)

DRUG DESCRIPTION



What are the possible side effects of becaplermin topical (Regranex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using becaplermin topical and call your doctor at once if you have severe itching, redness, blistering, peeling, or other skin irritation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Regranex »




REGRANEX® Gel contains becaplermin, a recombinant human platelet-derived
growth factor (rhPDGF-BB) for topical administration. Becaplermin is produced
by recombinant DNA technology by insertion of the gene for the B chain of platelet-derived
growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin
has a molecular weight of approximately 25 KD and is a homodimer composed of
two identical poly-peptide chains that are bound together by disulfide bonds.
Becaplermin Concentrate is produced by Novartis Vaccines and Diagnostics, Inc.
and supplied to OMJ Pharmaceuticals under a shared manufacturing arrangement.
REGRANEX Gel is a non-sterile, low biobur-den, preserved, sodium carboxymethylcellulose-based
(CMC) topical gel, containing the active ingredient becaplermin and the following
inactive ingredients: sodium chloride, sodium acetate trihydrate, glacial acetic
acid, water for injection, and methyl-paraben, propylparaben, and m-cresol as
preservatives and l-lysine hydrochloride as a stabilizer. Each gram of REGRANEX
Gel contains 100 μg of becaplermin.Last reviewed on RxList: 11/17/2008




Regranex Drug Description
Regranex® Gel 0.01%
(becaplermin)

WARNING
An increased rate of mortality secondary to malignancy was observed in patients
treated with 3 or more tubes of REGRANEX Gel in a post-marketing retrospective
cohort study. REGRANEX Gel should only be used when the benefits can be expected
to outweigh the risks. REGRANEX Gel should be used with caution in patients
with known malignancy. (See CONTRAINDICATIONS
and WARNINGS)

DRUG DESCRIPTION



What are the possible side effects of becaplermin topical (Regranex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using becaplermin topical and call your doctor at once if you have severe itching, redness, blistering, peeling, or other skin irritation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Regranex »




REGRANEX® Gel contains becaplermin, a recombinant human platelet-derived
growth factor (rhPDGF-BB) for topical administration. Becaplermin is produced
by recombinant DNA technology by insertion of the gene for the B chain of platelet-derived
growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin
has a molecular weight of approximately 25 KD and is a homodimer composed of
two identical poly-peptide chains that are bound together by disulfide bonds.
Becaplermin Concentrate is produced by Novartis Vaccines and Diagnostics, Inc.
and supplied to OMJ Pharmaceuticals under a shared manufacturing arrangement.
REGRANEX Gel is a non-sterile, low biobur-den, preserved, sodium carboxymethylcellulose-based
(CMC) topical gel, containing the active ingredient becaplermin and the following
inactive ingredients: sodium chloride, sodium acetate trihydrate, glacial acetic
acid, water for injection, and methyl-paraben, propylparaben, and m-cresol as
preservatives and l-lysine hydrochloride as a stabilizer. Each gram of REGRANEX
Gel contains 100 μg of becaplermin.Last reviewed on RxList: 11/17/2008




Regranex Drug Description
Regranex® Gel 0.01%
(becaplermin)

WARNING
An increased rate of mortality secondary to malignancy was observed in patients
treated with 3 or more tubes of REGRANEX Gel in a post-marketing retrospective
cohort study. REGRANEX Gel should only be used when the benefits can be expected
to outweigh the risks. REGRANEX Gel should be used with caution in patients
with known malignancy. (See CONTRAINDICATIONS
and WARNINGS)

DRUG DESCRIPTION



What are the possible side effects of becaplermin topical (Regranex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using becaplermin topical and call your doctor at once if you have severe itching, redness, blistering, peeling, or other skin irritation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Regranex »




REGRANEX® Gel contains becaplermin, a recombinant human platelet-derived
growth factor (rhPDGF-BB) for topical administration. Becaplermin is produced
by recombinant DNA technology by insertion of the gene for the B chain of platelet-derived
growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin
has a molecular weight of approximately 25 KD and is a homodimer composed of
two identical poly-peptide chains that are bound together by disulfide bonds.
Becaplermin Concentrate is produced by Novartis Vaccines and Diagnostics, Inc.
and supplied to OMJ Pharmaceuticals under a shared manufacturing arrangement.
REGRANEX Gel is a non-sterile, low biobur-den, preserved, sodium carboxymethylcellulose-based
(CMC) topical gel, containing the active ingredient becaplermin and the following
inactive ingredients: sodium chloride, sodium acetate trihydrate, glacial acetic
acid, water for injection, and methyl-paraben, propylparaben, and m-cresol as
preservatives and l-lysine hydrochloride as a stabilizer. Each gram of REGRANEX
Gel contains 100 μg of becaplermin.Last reviewed on RxList: 11/17/2008




Regranex Drug Description
Regranex® Gel 0.01%
(becaplermin)

WARNING
An increased rate of mortality secondary to malignancy was observed in patients
treated with 3 or more tubes of REGRANEX Gel in a post-marketing retrospective
cohort study. REGRANEX Gel should only be used when the benefits can be expected
to outweigh the risks. REGRANEX Gel should be used with caution in patients
with known malignancy. (See CONTRAINDICATIONS
and WARNINGS)

DRUG DESCRIPTION



What are the possible side effects of becaplermin topical (Regranex)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using becaplermin topical and call your doctor at once if you have severe itching, redness, blistering, peeling, or other skin irritation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at...
Read All Potential Side Effects for Regranex »




REGRANEX® Gel contains becaplermin, a recombinant human platelet-derived
growth factor (rhPDGF-BB) for topical administration. Becaplermin is produced
by recombinant DNA technology by insertion of the gene for the B chain of platelet-derived
growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin
has a molecular weight of approximately 25 KD and is a homodimer composed of
two identical poly-peptide chains that are bound together by disulfide bonds.
Becaplermin Concentrate is produced by Novartis Vaccines and Diagnostics, Inc.
and supplied to OMJ Pharmaceuticals under a shared manufacturing arrangement.
REGRANEX Gel is a non-sterile, low biobur-den, preserved, sodium carboxymethylcellulose-based
(CMC) topical gel, containing the active ingredient becaplermin and the following
inactive ingredients: sodium chloride, sodium acetate trihydrate, glacial acetic
acid, water for injection, and methyl-paraben, propylparaben, and m-cresol as
preservatives and l-lysine hydrochloride as a stabilizer. Each gram of REGRANEX
Gel contains 100 μg of becaplermin.Last reviewed on RxList: 11/17/2008





Other reviews about Becaplermin on wordpress

Use of External Ring Fixation in a Full-Thickness Achilles Wound: A Case Report
  by FAOJ Editors
by Lee C. Rogers, DPM 1, Nicholas J. Bevilacqua, DPM 2, Kenneth Francis, MD 3, Michael C. Piccarelli, DPM 4 The Foot & Ankle Journal 1 (3): 4 An […]


FDA investigates link between becaplermin (Regranex) gel and risk of cancer death
  by Moderator
NeLM-The FDA is conducting a safety review of becaplermin (Regranex®) gel, a recombinant form of human platelet-derived growth factor which is used to treat diabetic foot and leg […]


Monday March 31, 2008
  by pharmaweenie
ChronicleMONDAY From the publishers of THE CHRONICLE OF CANCER THERAPY, THE CHRONICLE OF CARDIOVASCULAR & INTERNAL MEDICINE, THE CHRONICLE OF NEUROLOGY & PSYCHIATY, THE CHRONICLE OF […]


FDA Adds Cancer Risk to Diabetic Foot Ulcer-Drug Label
  by Theresa Tamkins
Regranex Gel 0.01% (becaplermin), a cream used to treat diabetic foot ulcers, will now carry a “boxed warning” on its label after a study found a greater number […]


FDA News Digest June 9, 2008
  by fansaviola
FDA News Digest June 9, 2008 _____________________________________     IN THIS WEEK'S ISSUE   »  News     -- New Warning Planned for Diabetic Ulcer Cream Regranex     -- Heartworm Drug ProHeart 6 to Have Limited Return […]


Creepyhollows Medication List
  by creepyhollowsawareness
The following list has been copied from a page on the Creepy Hollows website which may be viewed here.  We present this  as evidence  of cultic manipulation within […]


The Wound Healing Spectrum: A Timeline for the Utilization of Advanced Technology
  by jdfceditors
Authors: Ryan H. Fitzgerald, DPM 1, Lee C. Rogers, DPM 2, David G. Armstrong, DPM 3 The Journal of Diabetic Foot Complications, Volume 1, Issue 3, No. 3, © […]


Against viruses
  by fidest
London. Non Adherent dressing is effective against viruses, fungi and over 150 strains of clinically relevant microorganisms in vitro, including MRSA, MRSE and VRE. Ongoing antimicrobial protection has […]


Biosimilars (2009 - 2014), healthcare-market-reports.com
  by hcaremarket
Report description Increasing pressure from patients, insurers and Government to reduce the expenditure and the expiration of patents of a number of blockbuster biopharmaceutical drugs; has created a large […]


Total Contact Casting for Neuropathic Ulcers: A Lost Art?
  by jdfceditors
Authors: Robert M. Greenhagen, DPM1, Dane K. Wukich, MD2 The Journal of Diabetic Foot Complications, Volume 1, Issue 4, No. 2, © 2009, all rights reserved. Abstract: As the diabetic epidemic […]



Other reviews about Becaplermin on web:

Learn about the prescription medication Regranex (Becaplermin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Regranex (Becaplermin) Drug Information: Uses, Side Effects, Drug ...


All about Becaplermin. View complete and up to date Becaplermin information - part of the Drugs.com trusted medication database. Becaplermin Facts and Comparisons at Drugs.com


Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Use for diabetic foot ulcers has been described. It is also known as "platelet-derived growth factor BB". Becaplermin - Wikipedia, the free encyclopedia


Consumer information about the medication BECAPLERMIN - TOPICAL GEL (Regranex), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... BECAPLERMIN - TOPICAL GEL (Regranex) side effects, medical uses ...


The reference site for becaplermin including news articles, images, and updated information Becaplermin.com - The official site for becaplermin information


Features product information and a guide to good foot care. REGRANEX Gel - diabetic footcare


becaplermin Topical (becaplermin) patient information. Detailed drug information for the consumer, includes dosage, becaplermin Topical side effects and more. becaplermin Topical consumer information from Drugs.com


Medical information about Diabetes Mellitus, Type 2, Type 1, and Metabolic Disorders treatment and medications. becaplermin - Diabetes Mellitus, Type 2 Diabetes, Type 1, and ...


Mayo Clinic offers award-winning medical and health information and tools for healthy living. Becaplermin (Topical Route) - MayoClinic.com


becaplermin /be·cap·ler·min/ (bĕ-kap´ler-min) a recombinant platelet-derived growth factor used in the treatment of chronic severe dermal ulcers of the lower limbs in diabetes ... becaplermin - definition of becaplermin in the Medical dictionary ...





Featured Reviews

Reviews Eltrombopag Tablets

Promacta Drug Description PROMACTA® (eltrombopag) Tablets WARNING: RISK FOR HEPATOTOXICITY PROMACTA may cause hepatotoxicity: Measure serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin prior...
Read More  |  Review This
Reviews Cocaine

Cocaine Drug Description Cocaine Hydrochloride Topical Solution NOT FOR INJECTION OR OPHTHALMIC USE. DRUG DESCRIPTION Each mL contains: Cocaine Hydrochloride 40 mg or 100 mg As aqueous solution. The topical solution contains...
Read More  |  Review This
Reviews Dibenzyline

Dibenzyline Drug Description DIBENZYLINE® (phenoxybenzamine hydrochloride) Capsules, USP 10 mg Adrenergic, Alpha-Receptor- blocking agent DRUG DESCRIPTION What are the possible side effects of phenoxybenzamine (Dibenzyline)? Get...
Read More  |  Review This
Reviews Thiopental Sodium

Pentothal Drug Description Pentothal (thiopental sodium) for Injection, USP DRUG DESCRIPTION What are the possible side effects of thiopental (Pentothal)? You will remain under constant supervision during treatment with thiopental....
Read More  |  Review This
Reviews EtheDent

EtheDent Drug Description EtheDent™ 1.1% SODIUM FLUORIDE (Sodium Fluoride, USP) Prescription Dental Cream DRUG DESCRIPTION Self-topical neutral fluoride dentifrice containing 1.1% (w/w) sodium fluoride for use as a dental...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....